Saturday, May 25, 2024
HomeMedicineInternal MedicineScientists develop a bioengineered oral pill to detect gastrointestinal conditions

Scientists develop a bioengineered oral pill to detect gastrointestinal conditions

Scientists have developed a novel bacterial based system as a tool to painlessly diagnose gastrointestinal conditions.

Engineers and scientists from Massachusetts Institute of Technology (MIT) in Massachusetts, USA, have developed an oral pill that could revolutionize the way we diagnose and manage gastrointestinal conditions. Diagnosing serious gastrointestinal conditions (for example drug-induced bleeding or ulcers) often requires using painful endoscopic methods, which are tiny cameras hooked up to a long winding tube that is inserted into the gut of the patient through oral or rectal route.

To reduce the pain associated with diagnosing gastrointestinal conditions there has been a growing demand for more non-invasive methods to monitor gastrointestinal conditions. To solve this problem investigators from MIT have utilized a system that combines the capabilities of a bacterial-based detection system and low-power microelectronic circuits in an oral pill.

The ingestible capsule houses bioengineered bacteria

The capsule is an ingestible micro-bioelectronics device (IMBED). At the heart of this capsule is a small chamber that houses bioengineered bacteria sandwiched between a porous membrane and an optical detector to capture light signal. These bacteria are non-toxic and akin to what is typically found in pro-biotic capsules taken to promote a healthy gastrointestinal environment.

The investigators carried out extensive testing of this system using a pig model to monitor gastric bleeding induced by painkiller indomethacin. The whole cell bacterial biosensor was designed to detect heme, a protein that is elevated when there is excessive bleeding induced by painkillers. The bacteria were also engineered to have a special transporter that allows this protein to be internalized.

Pill houses wireless transmission to an external device

The bacteria carry a small DNA cassette that is hooked to light producing gene. As the heme docks on to the DNA cassette engineered inside the bacteria, it turns on the expression of genes that produce tiny light signals (bioluminescence). In absence of heme the system remains in a “turned-off” condition and therefore no light is produced. This light produced by the interaction of heme with the DNA cassette is then detected by ultra-small optical detectors that are housed adjacent to the bacteria. The study showed remarkable results allowing for very precise detection of heme in pigs that had painkiller induced bleeding in the gut. What is even more exciting is that the pill houses small transmitters that allow for wireless transmission of the light signal to an external device such as a laptop or a mobile.

The scientists then engineered the system to detect substances other than heme that may be released into gut under pathological conditions. The system was able to detect acyl homoserine lactone (AHL) a compound that has been suggested to be found in gut following bacterial infections. Similarly, the system was also tested to detect thiosulfate, a compound which research suggests is frequently elevated in conditions of gut inflammation. What is particularly impressive is that the sensor can withstand the acidic environment that is present in the gastrointestinal tract. Their results have been published in Science.

Ongoing research to broaden the sensor’s applications

The authors suggested that such biosensors could be particularly useful in conditions where access with endoscopic methods is limited. Another potential advantage is direct detection of compounds in the gut that may be rapidly degraded before being excreted in the stool. The group is now focusing on broadening the application of the sensor to include detection of other compounds and pathological conditions.

Another focus of their research is to miniaturize the pill further to allow for easy ingestion of the device. However, given that the device is still the early stage of prototype testing, additional testing at preclinical and clinical phases will be required before it can be commercialized for human applications.

Written by Vinayak Khattar, Ph.D., M.B.A.

Reference: Mimee, M., Nadeau, P., Hayward, A., Carim, S., Flanagan, S., Jerger, L., . . . Lu, T. K. (2018). An ingestible bacterial-electronic system to monitor gastrointestinal health. Science, 360(6391), 915-918. doi:10.1126/science.aas9315

Vinayak Khattar PhD MBA
Vinayak Khattar PhD MBA
Vinayak Khattar completed his Master of Biotechnology at D.Y. Patil University in India. He received his Ph.D. in Cancer Biology at the University of Alabama at Birmingham (UAB) and then completed his M.B.A from the UAB Collat School of Business. His research interests lie in identifying mechanisms that dictate protein stability in cancer cells, immuno-oncology, and bone biology. He has seven peer-reviewed publications, over 40 citations, and three awards. He likes to watch Netflix documentaries with his family during his free time.


Please enter your comment!
Please enter your name here

Latest News and Articles


Stay Connected

Article of the month

Recognizing HIE: A Call for Advocacy

Have you heard of HIE? It’s the second leading cause of infant mortality and lifelong disability worldwide. 2-3 per 1,000 live births in high-income...

Joke Of The Day – May 25

Patient: Doctor, I am not feeling well. When I touch my chest, it hurts. When I check my pulse, I feel severe pain. When...


error: Content is read-only and copy-protected.